NeoGenomics, Inc. Long-Term Debt, Maturity, Remainder of Fiscal Year
NeoGenomics, Inc. (NEO) had Long-Term Debt, Maturity, Remainder of Fiscal Year of $2.81 million as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Commitment and Contingencies
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear · last filed 2017-05-09
- 2017-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $2.81M.
- 2016-09-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $161.00K.
- 2016-06-30: Long-Term Debt, Maturity, Remainder of Fiscal Year $311.00K.
- 2016-03-31: Long-Term Debt, Maturity, Remainder of Fiscal Year $453.00K.
| Period end | Long-Term Debt, Maturity, Remainder of Fiscal Year |
|---|---|
| 2017-03-31 | $2.81M 10-Q · filed 2017-05-09 |
| 2016-09-30 | $161.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $311.00K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $453.00K 10-Q · filed 2016-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |